Home

BeyondTrust adds clarity to reduce password management risks

PHOENIX: BeyondTrust has announced BeyondTrust PowerBroker Password Safe 5.5. The new version of BeyondTrust’s privileged password management and privileged session management solution enables data feeds from privileged password activity, user and account behavior to be incorporated into the Clarity threat analytics capabilities of BeyondInsight, the company’s IT Risk Management Platform. Further enhancements include securing the use of SSH keys, simplifying the administration of dual accounts, new deployment options and reporting capabilities, as well as expanded platform support.

: DAWN NICHOLLS; InfoSecurity; Posted On Monday, 13 April 2015 08:51

iCandy set to provide a show-stopping experience at The Pregnancy & Baby Fair

The leading luxury pushchair brand will give exhibitors the chance to purchase direct from iCandy for the first time and will be providing an unmissable giveaway at The Pregnancy & Baby Fair, Dublin and Cork

: THE EDITORIAL TEAM; Industry News; Posted On Monday, 13 April 2015 08:44

Tripwire to host RSA edition of Threat Intelligence University

LONDON, UK: Tripwire, Inc., the global provider of advanced threat, security and compliance solutions, today announced a new virtual event titled “Tripwire Threat Intelligence University: RSA Edition.” The event will take place Tuesday, April 14, 2015.

: Lucy Harvey; Industry News; Posted On Friday, 10 April 2015 22:27

Aethlon Medical announces Ebola Humanitarian Use Device Submission to the FDA

SAN DIEGO: Aethlon Medical, Inc. has announced that it has submitted a Humanitarian Use Device submission to the United States Food and Drug Administration (FDA) to support potential market clearance of the Aethlon Hemopurifier® as a treatment for Ebola virus. The Hemopurifier is a first-in-class bio-filtration device designed for the single-use removal of viruses and shed glycoproteins from the circulatory system of infected individuals. The device targets antiviral drug resistance and could serve as a first-line countermeasure against Ebola and other viruses that are not addressed with proven drug therapies.